SpringWorks Therapeutics, Inc..
SWTX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
SpringWorks Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing life-changing medicines for patients with severe rare diseases and cancer. The company's lead product is Ogsiveo (nirogacestat), an oral gamma secretase inhibitor approved for the...Show More
Better Health for All
-20
SpringWorks Therapeutics focuses on developing and commercializing medicines for severe rare diseases and cancer, with its entire portfolio dedicated to these health-positive outcomes. The company's products, OGSIVEO and GOMEKLI, are approved for conditions like desmoid tumors and neurofibromatosis type 1, aiming to reduce disease progression and improve quality of life.
1
SpringWorks offers patient assistance programs (PAPs) for Ogsiveo and Gomekli, providing free medication for eligible individuals and a $0 copay option for commercially insured patients, and also offers quick start and bridge programs for temporary free supply.
2
The company provides access to investigational therapies through compassionate use programs for patients with serious, debilitating, or life-threatening conditions.
3
SpringWorks follows regulatory policies for scientific and educational activities and discloses expenditures to healthcare providers under the Sunshine Act.
4
However, the company's products have significant reported adverse reactions: OGSIVEO had serious adverse reactions in 20% of patients, and GOMEKLI in 17% of adult and 14% of pediatric patients.
5
The company's Employee Resource Groups (ERGs) focus on internal inclusion and employee well-being, including mental and physical health, but there is no evidence of external health equity programs or support for the broader healthcare workforce beyond requiring HCPs to oversee treatment in expanded access programs.
6
SpringWorks also supports medical education and sponsorships to advance medical care and scientific research.
7
Fair Money & Economic Opportunity
0
No evidence available to assess SpringWorks Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
40
The company's CEO pay ratio was 36:1 in 2024, with the CEO earning $16,153,317 and the median employee earning $454,858.
1
All full-time employees receive 100% employer-funded health insurance coverage for medical, dental, and vision, which also extends to dependents up to age 30.
2
Employee feedback indicates an overall rating of 4.2 out of 5 stars (84%), with 76% of employees stating they would recommend working there and 67% approving of the CEO.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess SpringWorks Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess SpringWorks Therapeutics, Inc. on Honest & Fair Business.
Kind to Animals
-50
SpringWorks Therapeutics Inc. is listed as engaging in animal testing.
1
There is no evidence of a formal policy from the company to restrict or reduce animal testing.
2
No War, No Weapons
0
No information relevant to SpringWorks Therapeutics, Inc. and the 'No War, No Weapons' value, or any of the specified KPIs, was found in the provided articles.
1
The articles either contained error messages or explicitly stated a lack of relevant information regarding arms contracts, dual-use technology, sales to embargoed regimes, peacebuilding investments, or any other related metrics.
2
Planet-Friendly Business
0
No specific, quantitative data points related to planet-friendly business practices were found in the provided articles.
1
The articles primarily discuss ESG risk ratings or explicitly state an absence of relevant sustainability metrics, preventing an assessment against the defined KPIs.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles for SpringWorks Therapeutics, Inc. (SWTX.US) regarding its respect for cultures and communities.
1
The articles either pertained to a different entity or were irrelevant instruction manuals, thus providing no evidence for any of the defined KPIs.
2
Safe & Smart Tech
0
No evidence available to assess SpringWorks Therapeutics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles.